Biotech

All Articles

Amgen files first period 3 win for $400M chronic eczema medicine

.Amgen has actually shared (PDF) the first phase 3 data on its own $400 million dermatitis medicine,...

Biogen, UCB report stage 3 lupus win after falling short earlier test

.Biogen and also UCB's gamble on improving into stage 3 astride a failed study looks to have actuall...

Aptadir wishes brand new RNA preventions may turn around difficult cancers cells

.Italian biotech Aptadir Therapeutics has actually introduced along with the pledge that its own pip...

Wave surfs DMD success to regulators' doors, delivering stock up

.Wave Life Sciences has actually fulfilled its own goal in a Duchenne muscle dystrophy (DMD) study, ...

Sanofi picks new CSO coming from in-stealth biotech

.After a couple of years in biotech, Mike Quigley, Ph.D., is coming back to the pharma crease, takin...

Achilles splashes tissue therapy plan, bandages for unemployments after overlooking 'business viability' objectives

.Achilles Rehabs has shreded its own approach. The British biotech is actually quiting working on it...

Aligos advertises phase 2 MASH succeed, reducing liver excess fat up to 46%

.Aligos Therapeutics is actually declaring a midstage gain in metabolic-dysfunction connected steato...

Basilea ratings $268M BARDA financing for antifungals, antibiotics

.Basilea Pharmaceutica's job building brand-new antifungals has actually gotten a substantial increa...

Capricor offers Europe liberties to late-stage DMD therapy for $35M

.Having presently scooped up the U.S. rights to Capricor Therapeutics' late-stage Duchenne muscular ...

FDA junks adcomm for Applied's unusual illness medication

.After pushing back the decision date for Applied Rehabs' metabolic problem medication govorestat, t...